Tag: Victoza (liraglutide)

August 25, 2017 Off

FDA OK’s Novo Nordisk’s diabetes drug

By Dino Mustafić

The U.S. Food and Drug Administration (FDA) has approved a new indication for Novo Nordisk’s Victoza (liraglutide) to reduce the risk of major adverse cardiovascular (CV) events in adults with type 2 diabetes and established CV disease.